The Adcom Group Revenue and Competitors

Location

N/A

Total Funding

Marketing

Industry

Estimated Revenue & Valuation

  • The Adcom Group's estimated annual revenue is currently $32.8M per year.(i)
  • The Adcom Group's estimated revenue per employee is $232,270

Employee Data

  • The Adcom Group has 141 Employees.(i)
  • The Adcom Group grew their employee count by 10% last year.

The Adcom Group's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief StaffReveal Email/Phone
3
Chief Marketing OfficerReveal Email/Phone
4
VP, Account Strategy and ManagementReveal Email/Phone
5
VP - FinanceReveal Email/Phone
6
VP OperationsReveal Email/Phone
7
VP Account Strategy & ManagementReveal Email/Phone
8
EVPReveal Email/Phone
9
Senior Motion DirectorReveal Email/Phone
10
Senior Art DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.4M15-6%N/AN/A
#2
$8.6M432%N/AN/A
#3
$79.8M2830%N/AN/A
#4
$38.5M136-1%N/AN/A
#5
$0.9M5-29%N/AN/A
#6
$7.6M32-14%N/AN/A
#7
$7.4M23-36%N/AN/A
#8
$2.6M170%N/AN/A
#9
$3.9M2514%N/AN/A
#10
$12.6M574%N/AN/A
Add Company

What Is The Adcom Group?

Adcom, founded in 1990, is a leading marketing and PR firm in the Midwest that does work in health care, trades, transportation and consumer goods, among other industries. Clients include some of the region's and nation's most prominent companies

keywords:N/A

N/A

Total Funding

141

Number of Employees

$32.8M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

The Adcom Group News

2022-03-30 - Amylyx ALS Candidate Denied in Painfully Close AdCom Vote ...

In the study, which was comprised of 137 participants, AMX0035 showed a 6 ½ month survival benefit for the treatment group.

2022-03-22 - UPDATED: Amylyx - and Hopeful ALS Community – Face ...

“The FDA needs to do the same thing for ALS as they did for Alzheimer's,” Nicole Cimbura, co-lead for the legislative affairs team at...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M1446%N/A
#2
$56.1M144-10%N/A
#3
$67.9M1454%N/A
#4
$35.7M14525%N/A
#5
$54.8M14524%N/A